A Product Advisory is a voluntary letter issued to inform physicians of an anomalous device behavior identified by Boston Scientific's Quality System. A Product Advisory is issued when there is a material elevation in risk to patient safety, potential for compromised lifesaving therapy, or when Boston Scientific can provide meaningful guidance to improve patient outcomes or device performance.
Boston Scientific resumes U.S. distribution of all CRT-Ds and ICDs.
Physician letter dated May 2010
Patient letter dated May 2010
